Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 6.60% is 23% above its 5-year average of 5.35%, near the high end of its 5-year range (-0.60%–7.96%).
1.86% below its 12-month average of 6.73%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.96%.
NET PROFIT MARGIN
6.60%
NET PROFIT MARGIN AVG TTM
6.73%
NET PROFIT MARGIN AVG 3Y
6.81%
NET PROFIT MARGIN AVG 5Y
5.35%
NET PROFIT MARGIN AVG 10Y
4.92%
NET PROFIT MARGIN AVG 15Y
5.37%
NET PROFIT MARGIN AVG 20Y
5.49%
CURRENT VS TTM AVG
-1.86%
CURRENT VS 3Y AVG
-3.11%
CURRENT VS 5Y AVG
+23.34%
CURRENT VS 10Y AVG
+34.03%
CURRENT VS 15Y AVG
+22.82%
CURRENT VS 20Y AVG
+20.16%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 717 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
HealthStream, Inc.
Market Cap
$914.32M
Net Profit Margin
6.60%
TTM Avg
6.73%
3Y Avg
6.81%
5Y Avg
5.35%
Market Cap
$897.81M
Net Profit Margin
84.23%
TTM Avg
-685.46%
3Y Avg
-487.63%
5Y Avg
-594.40%
Market Cap
$897.98M
Net Profit Margin
9.36%
TTM Avg
-0.92%
3Y Avg
-15.83%
5Y Avg
-8.95%
Market Cap
$933.58M
Net Profit Margin
-64.73%
TTM Avg
-60.89%
3Y Avg
-82.58%
5Y Avg
-82.58%
Market Cap
$887.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$938.53M
Net Profit Margin
-4994.86%
TTM Avg
-4994.86%
3Y Avg
-4994.86%
5Y Avg
-4994.86%
Market Cap
$948.70M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$876.73M
Net Profit Margin
116.30%
TTM Avg
67.23%
3Y Avg
16.07%
5Y Avg
4.15%
Market Cap
$956.88M
Net Profit Margin
-384.30%
TTM Avg
-367.92%
3Y Avg
-183.96%
5Y Avg
-122.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $914.32M | 6.60% | 6.73% | 6.81% | 5.35% |
| Arbutus Biopharma Corp (ABUS)vs › | $897.81M | 84.23% | -685.46% | -487.63% | -594.40% |
| Bioventus Inc. (BVS)vs › | $897.98M | 9.36% | -0.92% | -15.83% | -8.95% |
| CeriBell, Inc. (CBLL)vs › | $933.58M | -64.73% | -60.89% | -82.58% | -82.58% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $938.53M | -4994.86% | -4994.86% | -4994.86% | -4994.86% |
| MoonLake Immunotherapeutics (MLTX)vs › | $948.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $876.73M | 116.30% | 67.23% | 16.07% | 4.15% |
| Kura Oncology, Inc. (KURA)vs › | $956.88M | -384.30% | -367.92% | -183.96% | -122.64% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $858.40M | -560.85% | -63.69% | -31.84% | -21.23% |
Operating Margin
8.0%
Net Profit Margin
6.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 7.96% |
| 2026-03-31 | 7.28% |
| 2025-12-31 | 3.18% |
| 2025-09-30 | 7.96% |
| 2025-06-30 | 7.24% |
| 2025-03-31 | 5.90% |
| 2024-12-31 | 6.59% |
| 2024-09-30 | 7.83% |
| 2024-06-30 | 5.82% |
| 2024-03-31 | 7.18% |
| 2023-12-31 | 6.50% |
| 2023-09-30 | 5.50% |
| 2023-06-30 | 5.97% |
| 2023-03-31 | 3.80% |
| 2022-12-31 | 3.57% |
| 2022-09-30 | 5.45% |
| 2022-06-30 | 4.70% |
| 2022-03-31 | 4.43% |
| 2021-12-31 | -0.60% |
| 2021-09-30 | 2.34% |
| 2021-06-30 | 3.77% |
| 2021-03-31 | 3.61% |
| 2020-12-31 | 1.49% |
| 2020-09-30 | 4.33% |
| 2020-06-30 | 5.68% |
| 2020-03-31 | 11.52% |
| 2019-12-31 | 5.87% |
| 2019-09-30 | 5.94% |
| 2019-06-30 | 3.76% |
| 2019-03-31 | 9.16% |
| 2018-12-31 | 4.66% |
| 2018-09-30 | 5.07% |
| 2018-06-30 | 4.46% |
| 2018-03-31 | 43.47% |
| 2017-12-31 | 6.29% |
| 2017-09-30 | 3.94% |
| 2017-06-30 | 3.69% |
| 2017-03-31 | 2.15% |
| 2016-12-31 | -0.53% |
| 2016-09-30 | 1.99% |
| 2016-06-30 | 2.56% |
| 2016-03-31 | 2.78% |
| 2015-12-31 | 3.24% |
| 2015-09-30 | 4.86% |
| 2015-06-30 | 2.82% |
| 2015-03-31 | 5.77% |
| 2014-12-31 | 5.84% |
| 2014-09-30 | 7.72% |
| 2014-06-30 | 5.57% |
| 2014-03-31 | 5.08% |
| 2013-12-31 | 4.75% |
| 2013-09-30 | 6.82% |
| 2013-06-30 | 7.59% |
| 2013-03-31 | 6.55% |
| 2012-12-31 | 6.54% |
| 2012-09-30 | 7.49% |
| 2012-06-30 | 9.39% |
| 2012-03-31 | 6.00% |
| 2011-12-31 | 8.19% |
| 2011-09-30 | 8.71% |
| 2011-06-30 | 8.70% |
| 2011-03-31 | 8.24% |
| 2010-12-31 | 6.83% |
| 2010-09-30 | 4.79% |
| 2010-06-30 | 8.09% |
| 2010-03-31 | 5.44% |
| 2009-12-31 | 68.54% |
| 2009-09-30 | 7.25% |
| 2009-06-30 | 11.85% |
| 2009-03-31 | 6.44% |
| 2008-12-31 | 10.67% |
| 2008-09-30 | 4.46% |
| 2008-06-30 | 5.68% |
| 2008-03-31 | 0.58% |
| 2007-12-31 | 24.01% |
| 2007-09-30 | 6.26% |
| 2007-06-30 | 3.53% |
| 2007-03-31 | 0.55% |
| 2006-12-31 | 12.60% |
| 2006-09-30 | 6.34% |
| 2006-06-30 | 3.51% |
| 2006-03-31 | 8.75% |
| 2005-12-31 | 14.82% |
| 2005-09-30 | 8.11% |
| 2005-06-30 | 0.34% |
| 2005-03-31 | 2.54% |
| 2004-12-31 | 1.41% |
| 2004-09-30 | -3.52% |
| 2004-06-30 | -11.28% |
| 2004-03-31 | -8.54% |
| 2003-12-31 | -8.78% |
| 2003-09-30 | -14.35% |
| 2003-06-30 | -21.60% |
| 2003-03-31 | -30.78% |
| 2002-12-31 | -63.78% |
| 2002-09-30 | -58.67% |